Prudential PLC
11 November 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
Prudential plc
2. Name of director
Jonathan Bloomer, Philip Broadley, Sir David Clementi, Michael McLintock,
Kathleen O'Donovan, James Ross, Robert Rowley, G Mark Wood
3. Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in
respect of a non-beneficial interest Directors named above & spouse where
applicable
4. Name of the registered holder(s) and, if more than one holder, the number
of shares held by each of them (if notified)
Jonathan Bloomer & A E J Bloomer - in own name
Jonathan Bloomer - shares held in Strand Nominees Account, Charles Stanley
Asset Management ISA and a Prudential PEP
Philip Broadley & G E Broadley - in own name
Sir David Clementi & Lady Clementi - shares held in Kleinwort Benson
Nominee Account
Michael McLintock - in own name and Brewin Nominees Limited Account
Kathleen O'Donovan - shares held in James Capel Nominees ISA
James Ross - in own name
Robert Rowley - in own name
Robert Rowley & Judith Rowley - shares held in Halifax ISA
G Mark Wood - in own name
5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)
See point 7
6. Please state the nature of the transaction. For PEP/ISA transactions please
indicate whether general/single co PEP and if discretionary/
non discretionary
Take up of shares under the Prudential plc Rights Issue
7. Number of shares / amount of stock acquired
Jonathan Bloomer
1,326 ordinary shares (1,010 shares in the name of the Director and 316
shares in the name of his spouse)
Strand Nominee Account - 25,826 ordinary shares
Charles Stanley Asset management ISA - 143 ordinary shares
Prudential PEP - 231 ordinary shares
Philip Broadley
2,436 ordinary shares (2,339 shares in the name of the Director and 97
shares in the name of his spouse)
Sir David Clementi
2,373 ordinary shares (2,234 shares in the name of the Chairman and 139
shares in the name of his spouse)
Michael McLintock
177 ordinary shares in his name
Brewin Nominees Limited - 7,778 ordinary shares
Kathleen O'Donovan - 416 ordinary shares
James Ross - 630 ordinary shares
Robert Rowley
4,117 ordinary shares in his own name
Halifax ISA 1,588 ordinary shares (862 shares in the name of the Director
and 726 shares in the name of his spouse)
G Mark Wood - 5,118 ordinary shares
8. Percentage of issued class
Jonathan Bloomer Less than 0.002%
Philip Broadley Less than 0.0002%
Sir David Clementi Less than 0.0001%
Michael McLintock Less than 0.0004%
Kathleen O'Donovan Less than 0.00002%
James Ross - Less than 0.00003%
Robert Rowley Less than 0.0003%
G Mark Wood Less than 0.0003%
9. Number of shares/amount of stock disposed
N/A
10. Percentage of issued class
N/A
11. Class of security
Prudential ordinary shares of 5p each
12. Price per share
308p
13. Date of transaction
11 November 2004
14. Date company informed
11 November 2004
15. Total holding following this notification
Jonathan Bloomer (1,668,339 ordinary shares)
Philip Broadley ( 443,749 ordinary shares)
Sir David Clementi (16,615 ordinary shares)
Michael McLintock (245,154 ordinary shares)
Kathleen O'Donovan (6,893 ordinary shares)
James Ross (4,414 ordinary shares)
Robert Rowley (40,248 ordinary shares)
G Mark Wood (577,542 ordinary shares)
16. Total percentage holding of issued class following this notification
Jonathan Bloomer Less than 0.08%
Philip Broadley Less than 0.02%
Sir David Clementi Less than 0.0007%
Michael McLintock Less than 0.02%
Kathleen O'Donovan Less than 0.0003%
James Ross - Less than 0.0002%
Robert Rowley Less than 0.002%
G Mark Wood Less than 0.03%
If a director has been granted options by the company please complete the
following boxes.
17. Date of grant
N/A
18. Period during which or date on which exercisable
N/A
19. Total amount paid (if any) for grant of the option
N/A
20. Description of shares or debentures involved: class, number
N/A
21. Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise
N/A
22. Total number of shares or debentures over which options held following this
notification
N/A
23. Any additional information
24. Name of contact and telephone number for queries
Jennie Webb, 020 7548 6027
25. Name and signature of authorised company official responsible for making
this notification
Robert Walker, Deputy Group Secretary, 020 7548 3848
Date of Notification
11 November 2004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.